{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:26:29Z","timestamp":1744259189911,"version":"3.40.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.diagmicrobio.2025.116793","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T22:51:10Z","timestamp":1741474270000},"page":"116793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotics beyond bacteria: Novel immunomodulation strategies for periodontal diseases"],"prefix":"10.1016","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6843-592X","authenticated-orcid":false,"given":"Mohammad Amin","family":"Amiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahram","family":"Hamedani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farnaz","family":"Haji Abbas Oghli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.781378","article-title":"Immunomodulation in the treatment of periodontitis: progress and perspectives","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0002","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pharmthera.2007.11.001","article-title":"Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action","volume":"117","author":"Shinkai","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0003","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1874467210801010068","article-title":"Immunomodulatory properties of antibiotics","volume":"1","author":"Nau","year":"2008","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0004","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1128\/AAC.47.8.2649-2654.2003","article-title":"Reduced release of pneumolysin by Streptococcus pneumoniae in vitro and in vivo after treatment with nonbacteriolytic antibiotics in comparison to ceftriaxone","volume":"47","author":"Spreer","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0005","unstructured":"Spreer A., Stoltefaut V., Eiffert H., Nan R. Rifampicin followed by ceftriaxone after one hour reduces the release of toxic and proinflammatory bacterial compounds by Streptococcus pneumoniae in comparison to treatment with the bacteriolytic ceftriaxone alone. 2007."},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0006","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00006454-199912000-00014","article-title":"Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection","volume":"18","author":"Zimbelman","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12903-020-01276-3","article-title":"Clinical effects of probiotic or azithromycin as an adjunct to scaling and root planning in the treatment of stage III periodontitis: a pilot randomized controlled clinical trial","volume":"21","author":"Morales","year":"2021","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0008","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/adj.12674","volume":"64","author":"Liaw","year":"2019","journal-title":"Aust Dent J"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.574425","article-title":"Immunomodulatory effects of azithromycin revisited: potential applications to COVID-19","volume":"12","author":"Venditto","year":"2021","journal-title":"Front Immunol"},{"issue":"suppl_A","key":"10.1016\/j.diagmicrobio.2025.116793_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116793_bib0011","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0765.2011.01418.x","article-title":"Azithromycin in periodontal treatment: more than an antibiotic","volume":"47","author":"Hirsch","year":"2012","journal-title":"J Periodontal Res"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T22:26:24Z","timestamp":1744237584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0732889325001166"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116793","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotics beyond bacteria: Novel immunomodulation strategies for periodontal diseases","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116793","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116793"}}